Aberrant lipid metabolism reshapes the immune landscape in bone metastasis of nasopharyngeal carcinoma
Journal for ImmunoTherapy of Cancer · 2025-12 · 13 (12) · e012134
DOI: 10.1136/jitc-2025-012134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 12.12.2025. Verfasst von Yuanyuan Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Bone Neoplasms, Nasopharyngeal Carcinoma, Lipid Metabolism, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Foundation of Nanfang Hospital, Southern Medical University.
Abstract (Originalsprache)
Background
Bone metastasis (BM) drives therapeutic resistance and mortality in nasopharyngeal carcinoma (NPC). Tumor metabolites are crucial for NPC metastasis; however, the mechanisms by which these metabolites synergistically alter the immune microenvironment to promote BM remain unclear.
Methods
In this study, limited immune infiltration was observed in the NPC BM tumor microenvironment. Multiomics analysis has identified sphingosine kinase 1 (SPHK1) as a pivotal mediator driving BM and immune evasion in NPC, orchestrating the production of 1-phosphorylated sphingosine (S1P), which is critical for NPC pathogenesis.
Results
The aberrant buildup of lipid metabolites, along with immune microenvironment shifts, serves as a critical driver of NPC BM. Mechanistically, S1P enhanced osteoclast recruitment via S1PR3 binding and activated the Hippo pathway, worsening bone colonization and facilitating immune evasion by expanding the exhausted CD8 + T cell population.
Conclusions
The synergy between the SPHK1 inhibitor PF543 and anti-programmed cell death protein 1 therapy amplified treatment effectiveness beyond standalone approaches. Overall, the SPHK1/S1P pathway advances NPC growth and aids in suppressing immune defense. Regulation of lipid metabolism may be a therapeutic target against BM in NPC and may improve the effectiveness of immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Southern Medical University, Guangzhou, China.
- First Clinical Medical College, Southern Medical University, Guangzhou, China.
- Department of Otolaryngology, Head and Neck Surgery, Southern Medical University, Guangzhou, China clm520@i.smu.edu.cn 418897077@qq.com miyadoctor@163.com.
- Department of Radiation Oncology, Southern Medical University, Guangzhou, China clm520@i.smu.edu.cn 418897077@qq.com miyadoctor@163.com.
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Foundation of Nanfang Hospital, Southern Medical University
Zitieren
APA
Feng, Y., Wang, H., Zhu, Z., Deng, W., He, X., Yao, Y., Song, M., Peng, X., Lin, Y., & Cai, L. (2025). Aberrant lipid metabolism reshapes the immune landscape in bone metastasis of nasopharyngeal carcinoma. Journal for ImmunoTherapy of Cancer, 13(12), e012134. https://doi.org/10.1136/jitc-2025-012134
Vancouver
Feng Y, Wang H, Zhu Z, Deng W, He X, Yao Y, et al. Aberrant lipid metabolism reshapes the immune landscape in bone metastasis of nasopharyngeal carcinoma. Journal for ImmunoTherapy of Cancer. 2025;13(12):e012134. doi:10.1136/jitc-2025-012134
BibTeX
@article{Feng2025,
author = {Feng, Yuanyuan and Wang, Hongmei and Zhu, Ziyan and Deng, Wenxiang and He, Xiaoyue and Yao, Yingying and Song, Miao and Peng, Xiaohong and Lin, Yanling and Cai, Longmei},
title = {Aberrant lipid metabolism reshapes the immune landscape in bone metastasis of nasopharyngeal carcinoma},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2025},
volume = {13},
number = {12},
pages = {e012134},
doi = {10.1136/jitc-2025-012134}
}
EUVIMED